ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.895,75
-0,01%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,03165
0,38%
Bitcoin
107.172,57
3,94%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. IN8bio Inc (INAB)

  7. IN8bio Inc (INAB) News

INAB

IN8bio (INAB)

IN8bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:INAB
DatumZeitQuelleÜberschriftSymbolFirma
06/01/202513h00GlobeNewswire Inc.IN8bio to Present at Biotech Showcase 2025 in San FranciscoNASDAQ:INABIN8bio Inc
23/12/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
23/12/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
23/12/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
23/12/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
23/12/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
23/12/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
23/12/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
23/12/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
10/12/202413h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
10/12/202413h00GlobeNewswire Inc.IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual MeetingNASDAQ:INABIN8bio Inc
02/12/202413h00GlobeNewswire Inc.IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity ConferenceNASDAQ:INABIN8bio Inc
25/11/202413h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
25/11/202413h00GlobeNewswire Inc.IN8bio Reports Continued Durable Remissions in Phase 1 Trial of INB-200 in Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) Annual MeetingNASDAQ:INABIN8bio Inc
13/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INABIN8bio Inc
12/11/202422h45Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:INABIN8bio Inc
12/11/202422h33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INABIN8bio Inc
12/11/202422h26GlobeNewswire Inc.IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:INABIN8bio Inc
12/11/202413h00GlobeNewswire Inc.IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual MeetingNASDAQ:INABIN8bio Inc
05/11/202415h00GlobeNewswire Inc.IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual MeetingNASDAQ:INABIN8bio Inc
04/11/202422h31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INABIN8bio Inc
15/10/202422h04Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:INABIN8bio Inc
12/10/202400h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
08/10/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
08/10/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
08/10/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
01/10/202422h59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
01/10/202414h00GlobeNewswire Inc.IN8bio Announces Pricing of $12.4 Million Private PlacementNASDAQ:INABIN8bio Inc
11/09/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
06/09/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
 Showing the most relevant articles for your search:NASDAQ:INAB

Kürzlich von Ihnen besucht

LSE
67LS
Qnb Fin 25
FX
MXNGBP
MXN vs Sterling
LSE
0I4Y
Impact Developer & Contr...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten